Terms: = Leukemia AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Treatment
99 results:
1. Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial.
van der Maas NG; Versluis J; Nasserinejad K; van Rosmalen J; Pabst T; Maertens J; Breems D; Manz M; Cloos J; Ossenkoppele GJ; Floisand Y; Gradowska P; Löwenberg B; Huls G; Postmus D; Pignatti F; Cornelissen JJ
Blood Cancer J; 2024 Mar; 14(1):56. PubMed ID: 38538587
[TBL] [Abstract] [Full Text] [Related]
2. Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial.
Kater AP; Arslan Ö; Demirkan F; Herishanu Y; Ferhanoglu B; Diaz MG; Leber B; Montillo M; Panayiotidis P; Rossi D; Skarbnik A; Tempescul A; Turgut M; Mellink CH; van der Kevie-Kersemaekers AF; Lanham S; Sale B; Del Rio L; Popovic R; Chyla BJ; Busman T; Komlosi V; Wang X; Sail K; Pena GE; Vizkelety T; Forconi F
Lancet Oncol; 2024 Apr; 25(4):463-473. PubMed ID: 38467131
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of clinical profile and role of various prognostic factors in early bone marrow response in children with acute lymphoblastic leukemia treated by Modified Multicenter Protocol (MCP) 841 protocol: Experience from a tertiary care center in North India.
Garg M; Abrol P; Gupta N; Bharti S; Nadda A
Indian J Cancer; 2023 Oct; 60(4):521-527. PubMed ID: 38258870
[TBL] [Abstract] [Full Text] [Related]
4. Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients.
Zhou X; Weng Y; Jiang T; Ou W; Zhang N; Dong Q; Tang X
BMC Cancer; 2023 Oct; 23(1):976. PubMed ID: 37833648
[TBL] [Abstract] [Full Text] [Related]
5. The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid leukemia Patients: A Single-Center Retrospective Study.
Liu D; Wang X; Tong J; Zhou L; Chen E; Zhou Z; Xue L; Zhang X; Sun G; Zheng C
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676738
[No Abstract] [Full Text] [Related]
6. Venetoclax in Combination with Azacitidine for the treatment of Newly Diagnosed Acute Myeloid leukemia: A Canadian Cost-Utility Analysis.
Guinan K; Mathurin K; Au Y; Schuh AC; Bui CN; Chai X; Lachaine J
Curr Oncol; 2022 Oct; 29(10):7524-7536. PubMed ID: 36290869
[TBL] [Abstract] [Full Text] [Related]
7. Description of PTPRG genetic variants identified in a cohort of Chronic Myeloid leukemia patients and their ability to influence response to Tyrosine kinase Inhibitors.
Ismail MA; Nasrallah GK; Monne M; AlSayab A; Yassin MA; Varadharaj G; Younes S; Sorio C; Cook R; Modjtahedi H; Al-Dewik NI
Gene; 2022 Mar; 813():146101. PubMed ID: 34906644
[TBL] [Abstract] [Full Text] [Related]
8. Lactucin induces apoptosis through reactive oxygen species-mediated BCL-2 and CFLAR
Jang JH; Park CY; Sung EG; Song IH; Kim JY; Jung C; Sohn HY; Lee TJ
Genes Genomics; 2021 Oct; 43(10):1199-1207. PubMed ID: 34302634
[TBL] [Abstract] [Full Text] [Related]
9. Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from CYP-C.
Pelland-Marcotte MC; Kulkarni K; Athale UH; Pole JD; Brandão LR; Sung L
Am J Hematol; 2021 Jul; 96(7):796-804. PubMed ID: 33848369
[TBL] [Abstract] [Full Text] [Related]
10. Mayo Clinic experience with 1123 adults with acute myeloid leukemia.
Begna KH; Ali W; Naseema Gangat ; Elliott MA; Al-Kali A; Litzow MR; Christopher Hook C; Wolanskyj-Spinner AP; Hogan WJ; Patnaik MM; Pardanani A; Zblewski DL; Chen D; He R; Viswanatha D; Hanson CA; Ketterling RP; Tefferi A
Blood Cancer J; 2021 Mar; 11(3):46. PubMed ID: 33654065
[TBL] [Abstract] [Full Text] [Related]
11. H
Paul T; Roy R; Sarkar RD; Sinha S; Biswas N
Free Radic Biol Med; 2021 Apr; 166():265-276. PubMed ID: 33631302
[TBL] [Abstract] [Full Text] [Related]
12. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
Sharma A; Bhatt NS; St Martin A; Abid MB; Bloomquist J; Chemaly RF; Dandoy C; Gauthier J; Gowda L; Perales MA; Seropian S; Shaw BE; Tuschl EE; Zeidan AM; Riches ML; Shah GL
Lancet Haematol; 2021 Mar; 8(3):e185-e193. PubMed ID: 33482113
[TBL] [Abstract] [Full Text] [Related]
13. Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin.
Qin X; Huang C; Wu K; Li Y; Liang X; Su M; Li R
J Cell Mol Med; 2021 Jan; 25(2):677-685. PubMed ID: 33241658
[TBL] [Abstract] [Full Text] [Related]
14. Systematic Review of the Burden and treatment Patterns of Adult and Adolescent Acute Lymphoblastic leukemia in India: Comprehending the Challenges in an Emerging Economy.
Radhakrishnan VS; Agrawal N; Bagal B; Patel I
Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e85-e98. PubMed ID: 33189603
[TBL] [Abstract] [Full Text] [Related]
15. Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation Compared With Chemotherapy as Postremission treatment of Children With Intermediate-risk Acute Myeloid leukemia in First Complete Remission.
Xue YJ; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Suo P; Zhang LP; Huang XJ
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e126-e136. PubMed ID: 33060049
[TBL] [Abstract] [Full Text] [Related]
16. Magnolol Enhances the Therapeutic Effects of TRAIL through DR5 Upregulation and Downregulation of c-FLIP and Mcl-1 Proteins in Cancer Cells.
Woo SM; Min KJ; Kwon TK
Molecules; 2020 Oct; 25(19):. PubMed ID: 33050112
[TBL] [Abstract] [Full Text] [Related]
17. Clinicoepidemiologic Profile and Outcome Predicted by Minimal Residual Disease in Children With Mixed-phenotype Acute leukemia Treated on a Modified MCP-841 Protocol at a Tertiary Cancer Institute in India.
Myint HH; Tandon S; Narula G; Prasad M; Subramanian P; Patkar N; Tembhare P; Gujral S; Banavali S
J Pediatr Hematol Oncol; 2020 Oct; 42(7):415-419. PubMed ID: 32976349
[TBL] [Abstract] [Full Text] [Related]
18. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors.
Zeytün E; Altıntop MD; Sever B; Özdemir A; Ellakwa DE; Ocak Z; Ciftci HI; Otsuka M; Fujita M; Radwan MO
Anticancer Agents Med Chem; 2021; 21(9):1099-1109. PubMed ID: 32838725
[TBL] [Abstract] [Full Text] [Related]
19. Radiosensitizing Potential of Curcumin in Different Cancer Models.
Sak K
Nutr Cancer; 2020; 72(8):1276-1289. PubMed ID: 31648572
[TBL] [Abstract] [Full Text] [Related]
20. Amentoflavone Induces Apoptosis and Reduces Expression of Anti-apoptotic and Metastasis-associated Proteins in Bladder Cancer.
Chiang CH; Yeh CY; Chung JG; Chiang IT; Hsu FT
Anticancer Res; 2019 Jul; 39(7):3641-3649. PubMed ID: 31262890
[TBL] [Abstract] [Full Text] [Related]
[Next]
